NANKAI CHEMICAL COMPANY LIMITED AI Stock Analysis
Want to see JP:4040 full AI Analyst Report?
NANKAI CHEMICAL COMPANY LIMITED (4040) AI Stock Analysis
NANKAI CHEMICAL COMPANY LIMITED
(TSE/TYO:4040)
The score reflects a company in transition. The dominant driver is financial performance, where strong margin expansion and dramatic deleveraging are offset by a serious cash flow weakness — negative free cash flow and a projected negative operating cash flow undermine earnings quality. Valuation is the standout positive, with an exceptionally low 2.7x P/E implying significant upside if profitability proves durable, supported by a modest 1.63% dividend. Technically, the stock still holds above its 100- and 200-day averages but has lost short-term momentum, with price below its 20- and 50-day averages and a negative MACD. Overall, an attractively priced turnaround story that carries meaningful cash generation risk.
NANKAI CHEMICAL COMPANY LIMITED (4040) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 6.93B
- Dividend Yield
- 1.87%
- Average Volume (3M)
- 10.23K
- Price to Earnings (P/E)
- 2.2
- Beta (1Y)
- 1.08
- Revenue Growth
- -0.40%
- EPS Growth
- 215.27%
- Country
- Japan
- Employees
- 319
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
NANKAI CHEMICAL COMPANY LIMITED Business Overview & Revenue Model
Company Description
Established in 1906 and headquartered in Osaka, Japan, Nankai Chemical Company, Limited operates a diverse enterprise with a presence in both Japanese and international markets. The company's principal focus is the production and sale of a wide range...
NANKAI CHEMICAL COMPANY LIMITED Financial Statement Overview
Summary
Nankai Chemical shows a genuine turnaround on the income statement (Score 62): revenue up ~27% over five years to ¥20.9bn, gross margin expansion to ~28.4% and net income rising from ¥155m to a projected ¥2.78bn, though profitability has been uneven and FY2026 revenue is guided slightly lower. The balance sheet (Score 58) has improved markedly, with debt-to-equity falling from 2.06x to a projected 0.33x, equity nearly tripling and ROE projected near 25%, yet ¥3.7bn of debt remains and total assets have fluctuated. Cash flow is the clear weak link (Score 35): operating cash flow collapsed to ¥181m in FY2025 and turns negative in FY2026E, with negative free cash flow in three of six periods, signalling poor conversion of reported earnings into cash.
Income Statement
62PositiveBalance Sheet
58NeutralCash Flow
35Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.18B | 21.06B | 20.90B | 19.99B | 19.60B | 17.43B |
| Gross Profit | 6.21B | 5.98B | 5.51B | 5.50B | 4.50B | 4.13B |
| EBITDA | 3.21B | 2.92B | 2.44B | 2.59B | 1.80B | 1.72B |
| Net Income | 3.02B | 2.78B | 1.02B | 1.16B | 504.00M | 462.00M |
Balance Sheet | ||||||
| Total Assets | 19.49B | 19.55B | 22.47B | 20.26B | 18.35B | 17.22B |
| Cash, Cash Equivalents and Short-Term Investments | 1.95B | 2.04B | 1.70B | 1.71B | 1.30B | 1.28B |
| Total Debt | 3.38B | 3.68B | 5.64B | 5.21B | 6.07B | 7.41B |
| Total Liabilities | 7.89B | 8.38B | 13.96B | 12.75B | 13.15B | 12.54B |
| Stockholders Equity | 11.48B | 11.05B | 8.40B | 7.42B | 5.13B | 4.63B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -1.51B | -1.85B | 587.00M | 152.00M | 392.00M |
| Operating Cash Flow | 0 | -259.00M | 181.00M | 2.65B | 1.77B | 1.59B |
| Investing Cash Flow | 0 | 2.87B | -490.00M | -1.94B | -371.00M | -614.00M |
| Financing Cash Flow | 0 | -2.31B | 243.00M | -327.00M | -1.40B | -858.00M |
NANKAI CHEMICAL COMPANY LIMITED Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4040, the sentiment is Negative. The current price of 3470.00 is below the 20-day moving average (MA) of 4069.75, below the 50-day MA of 4042.83, and below the 200-day MA of 3630.96, indicating a bearish trend. The MACD of -113.40 indicates Positive momentum. The RSI at 27.51 is Positive, neither overbought nor oversold. The STOCH value of 12.15 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4040.
NANKAI CHEMICAL COMPANY LIMITED Peers Comparison
Overall Rating
JP:436071Outperform
JP:656863Neutral
JP:404061Neutral
JP:453159Neutral
JP:496044Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 71Outperform | JPY 7.68B | 8.10 | ― | 1.69% | 5.56% | ― | |
| 63Neutral | JPY 9.51B | 9.82 | ― | 2.70% | 23.75% | 40.75% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | JPY 8.09B | 2.21 | ― | 1.87% | -0.40% | 215.27% | |
| 59Neutral | JPY 6.66B | 13.77 | ― | 3.28% | 3.90% | -31.32% | |
| 44Neutral | JPY 6.97B | 18.23 | ― | 1.18% | 6.87% | 300.65% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4040 | NANKAI CHEMICAL COMPANY LIMITED | 3470.00 | 545.16 | 18.64% | |
| JP:4360 | MANAC Chemical Partners Co.,Ltd | 890.00 | 282.57 | 46.52% | |
| JP:4531 | Yuki Gosei Kogyo Co., Ltd. | 305.00 | 27.04 | 9.73% | |
| JP:4960 | Chemipro Kasei Kaisya,Ltd. | 424.00 | 109.37 | 34.76% | |
| JP:6568 | KNC Laboratories Co.,Ltd. | 1223.00 | 151.67 | 14.16% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026